Organization | Tottori University

Tottori University Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Founded: Tottori Japan (1949)

Organization Overview

First Clinical Trial

2004

NCT00664222

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2019

Timeline

NOW

Now

Alternative names

Tottori University | Tottori University Hospital | Tottori University,Tottori,Japan

Active Ingredients

Drugs in Phase 4 Trials (5)

benzbromarone (1 trial)

furosemide (lasix) (2 trials)

losartan (cozaar) (1 trial)

pioglitazone (actos) (1 trial)

spironolactone (aldactone) (2 trials)

Drugs in Phase 3 Trials (3)

ethinyl estradiol (Estinyl) (2 trials)

fludarabine (fludara) (1 trial)

norethindrone (2 trials)

Drugs in Phase 1 Trials (1)

bosutinib (bosulif) (1 trial)

Drugs in Other Trials (1)

leuprolide (lupron) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dysmenorrhea (Phase 3)

Heart Failure (Phase 4)

Hypertension (Phase 4)

Hyperuricemia (Phase 4)

Insulin Resistance (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 10